
|Videos|November 14, 2022
Dr. Meeks recaps LUGPA panel on optimizing advanced bladder cancer clinic
Author(s)Urology Times staff
"There's 3000 patient trials that are either done or going to be done within the next year or 2 in the BCG-naïve setting, and all of them have systemic therapy," says Joshua J. Meeks, MD, PhD.
Advertisement
Joshua J. Meeks, MD, PhD, is an associate professor of urology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois. In this interview, Meeks recaps a panel discussion on ABCC optimization, which took place at the
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves Titan Prime Inflatable Penile Prosthesis
2
Clint Bahler, MD, reflects on precision medicine and focal therapy highlights at AUA 2026
3
Pearls & Perspectives: Expanding Options for Men With Erectile Dysfunction, With Tom Riester
4
RAD-IO: Durvalumab plus chemoradiotherapy is feasible in MIBC
5











